Hiprabovis 3

País: Nova Zelanda

Idioma: anglès

Font: Ministry for Primary Industries

ingredients actius:

bovine viral diarrhoea virus (inactivated); parainfluenza-3 virus (inactivated); infectious bovine rhinotrocheitis virus (inactivated)

Disponible des:

Hipra New Zealand Limited

Designació comuna internacional (DCI):

bovine viral diarrhoea virus (inactivated), infectious bovine rhinotrocheitis virus (inactivated), parainfluenza-3 virus (inacti

Composición:

bovine viral diarrhoea virus (inactivated) 0 vaccine; parainfluenza-3 virus (inactivated) 0 vaccine; infectious bovine rhinotrocheitis virus (inactivated) 0 vaccine

Área terapéutica:

Vaccine

Estat d'Autorització:

ACVM Registered

Data d'autorització:

1997-04-01

Fitxa tècnica

REGISTRANT:
Hipra New Zealand Limited,
Level 2, Rsm House, 62
Highbrook Drive,
East Tamaki, Auckland, 2013, New Zealand
TRADE NAME:
HIPRABOVIS 3
ACVM NO.:
A007140
PREPARATION DATE:
17 January 2024
PAGE:
1 of 9
VIAL LABEL (5 DOSES)
MAIN PANEL
FOR ANIMAL TREATMENT ONLY
[refrigeration graphic]
RESTRICTED VETERINARY MEDICINE
HIPRABOVIS
®
3
Trivalent inactivated vaccine to stimulate active immunity against
respiratory and genital conditions in
cattle caused by Bovine Herpes Virus 1 (BoHV-1); i.e. IBR/IPV,
Parainfluenza Virus 3 (PI-3); and Bovine
Viral Diarrhoea (BVD)
5 doses (15 ml)
[cow graphic]
[Hipra logo]
VIAL LABEL (5 DOSES)
SIDE PANEL 1
COMPOSITION:
Inactivated viruses of BoHV-1, PI-3 and BVD.
Adjuvant.
INDICATIONS:
Refer to enclosed leaflet.
WITHHOLDINGPERIOD:
0 days.
Batch:
Exp.:
VIAL LABEL (5 DOSES)
SIDE PANEL 2
DOSAGE AND ADMINISTRATION:
CATTLE: 3 ml by subcutaneous or intramuscular injection.
Shake before use.
Store at +2 to +8 °C (refrigerated).
Read package leaflet before use.
ACVMNo. A007140
Manufactured by:
LABORATORIOS HIPRA, S.A.
Avda. la Selva, 135
17170 Amer (Girona) SPAIN
[Label identifier]
CONFIDENTIAL
REGISTRANT:
Hipra New Zealand Limited,
Level 2, Rsm House, 62
Highbrook Drive,
East Tamaki, Auckland, 2013, New Zealand
TRADE NAME:
HIPRABOVIS 3
ACVM NO.:
A007140
PREPARATION DATE:
17 January 2024
PAGE:
2 of 9
VIAL LABEL (30 OR 80 DOSES)
MAIN PANEL
FOR ANIMAL TREATMENT ONLY
[refrigeration graphic]
RESTRICTED VETERINARY MEDICINE
HIPRABOVIS
®
3
Trivalent inactivated vaccine to stimulate active immunity against
respiratory and genital conditions in
cattle caused by Bovine Herpes Virus 1 (BoHV-1); i.e. IBR/IPV,
Parainfluenza Virus 3 (PI-3); and Bovine
Viral Diarrhoea (BVD)
30 doses (90 ml)
80 doses (240 ml)
[cow
graphic]
[Hipra logo]
VIAL LABEL (30 OR 80 DOSES)
SIDE PANEL 1
COMPOSITION:
Inactivated viruses of BoHV-1, PI-3 and BVD.
Adjuvant.
DOSAGE AND ADMINISTRATION:
CATTLE: 3 ml by subcutaneous or intramuscular injection.
WITHHOLDINGPERIOD:
0 days.
Shake before use.
Store at +2 to +8 °C (refrigerat